原发性肺腺癌组织中巨噬细胞CD68+、CD163+的表达与临床病理学特征及预后相关性研究OA
Study on the Correlation between the Expression of CD68+and CD163+Macrophages in Primary Lung Adenocarcinoma Tissue and Their Clinical Pathological Characteristics and Prognosis
目的 探究原发性肺腺癌中巨噬细胞分化簇(CD)68+和CD163+的表达与临床病理学特征及预后相关性.方法 回顾性收集2018年1月至2019年6月在青岛市第八人民医院胸外科接受外科手术和辅助化疗的106例原发性肺腺癌患者的病理组织及癌旁组织标本,利用免疫组化法检测并比较肺腺癌组织和癌旁组织中CD68+和CD163+表达水平.计算高倍镜下肺腺癌组织和癌旁组织、癌巢和癌巢旁间质的CD68+和CD163+巨噬细胞密度,并依据中位密度区分癌巢/癌巢旁间质CD68+/CD163+高/低密度.随访原发性肺腺癌患者并统计生存期,采用Kaplan-Meier分析癌巢、癌巢旁间质中CD68+和CD163+巨噬细胞密度对原发性肺腺癌患者生存的影响.结果 CD68+和CD163+在肺腺癌组织中阳性表达所占比例均高于癌旁组织(χ2=15.881、13.904,均P<0.05).肺腺癌组织中CD68+和CD163+巨噬细胞密度高于癌旁组织(χ2=44.143、40.070,均P<0.05).癌巢、癌巢旁间质CD68+高密度组中III~Ⅳ期肺腺癌、T3肿瘤大小、N2~N3期淋巴结所占比例高于CD68+低密度组(χ2=6.788~10.604,均P<0.05).癌巢、癌巢旁间质CD163+高密度组中III~Ⅳ期肺腺癌、T3肿瘤大小、N2~N3期淋巴结所占比例高于CD163+低密度组(χ2=7.556~17.743,均P<0.05).癌巢CD68+高密度组的生存率59.32%(35/59)低于癌巢CD68+低密度组的生存率82.98%(39/47)(χ2=7.332,P<0.05);癌巢旁间质CD68+高密度组的生存率56.36%(31/55)低于癌巢旁间质CD68+低密度组的生存率84.31%(43/51)(χ2=9.518,P<0.05).癌巢CD163+高密度组的生存率58.93%(33/56)低于癌巢CD163+低密度组的生存率82.00%(41/50)(χ2=7.137,P<0.05);癌巢旁间质CD163+高密度组的生存率55.56%(30/54)低于癌巢旁间质CD163+低密度组的生存率84.62%(44/52)(χ2=12.487,P<0.05).结论 原发性肺腺癌组织中巨噬细胞CD68+和CD163+的密度较高,癌巢、癌巢旁间质CD68+和CD163+高密度与肺腺癌进展和浸润以及较低的生存率有关.
Objective To investigate the expression of macrophage clusters of differentiation(CD)68+ and CD163+ in primary lung adenocarcinoma and their correlation with clinical pathological characteristics and prognosis.Methods This study retro-spectively collected pathological tissue and adjacent tissue samples from 106 patients with primary lung adenocarcinoma who un-derwent surgical and adjuvant chemotherapy in the Department of Cardiothoracic Surgery of the Qingdao Eighth People's Hos-pital from January 2018 to June 2019.Immunohistochemistry was applied to detect and compare the expression levels of CD68+and CD163+ in lung adenocarcinoma tissue and adjacent tissue.Calculated the density of CD68+ and CD163+ macrophages in lung adenocarcinoma tissue andadjacent tissue,cancer nests and adjacent stroma under high magnification,and distinguished high/low density of CD68+/CD163+ in cancer nests/adjacent stroma based on median density.Primary lung adenocarcinoma pa-tients were followed up to measure survival time,and Kaplan-Meier was applied to analyze the impacts of densities of CD68+ and CD163+ macrophages in cancer nests and adjacent stroma on the survival of patients with primary lung adenocarcinoma.Results tissues(χ2=15.881,13.904,all P<0.05).The densities of CD68+ and CD163+ macrophages in lung adenocarcinoma tissues were higher than those in adjacent tissues(χ2=44.143,40.070,all P<0.05).The proportions of stage III-IV lung adenocarcinoma,T3 tumor size,and N2~N3 lymph nodes in the cancer nests and adjacent stroma CD68+ high-density groups were higher than those in the CD68+ low-density groups(χ2=6.788~10.604,all P<0.05).The proportions of stage III~IV lung adenocarcinoma,T3 tumor size,and N2~N3 lymph nodes in the cancer nests and adjacent stroma CD163+ high-density groups were higher than those in the CD163+ low-density groups(χ2=7.556~17.743,all P<0.05).The survival rate of high density of cancer nests CD68+ was 59.32%(35/59),which was lower than 82.98%(39/47)of low density of cancer nests CD68+(χ2=7.332,P<0.05);the survival rate of high density of adjacent stroma CD68+ was 56.36%(31/55),which was lower than 84.31%(43/51)of low density of adjacent stroma CD68+(χ2=9.518,P<0.05).The survival rate of high density of cancer nests CD163+ was 58.93%(33/56),which was lower than 82.00%(41/50)of low density of cancer nests CD163+(χ2=7.137,P<0.05);the survival rate of high density of adjacent stroma CD163+ was 55.56%(30/54),which was lower than 84.62%(44/52)of low density of adjacent stroma CD163+(χ2=12.487,P<0.05).Conclusions The densities of CD68+ and CD163+ macrophages are higher in primary lung adenocarcinoma tissues,and the high densities of CD68+ and CD163+ in cancer nests and adjacent stroma are associated with the progression and infiltration of lung adenocarcinoma,as well as a lower survival rate..
侯秋雨;季晓琳;罗强;张晨策;齐胜男;逄格硕;刘方波;魏亮
青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 病理科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000青岛市第八人民医院 心胸外科,山东 青岛 266000
医药卫生
原发性肺腺癌巨噬细胞CD68+CD163+病理特征
primary lung adenocarcinomamacrophagesclusters of differentiation 68+clusters of differentiation 163+pathological characteristics
《现代检验医学杂志》 2026 (1)
64-69,6
青岛市医药卫生科研指导项目(编号:2023-wjzd086).
评论